Job Description
Join our pioneering team at BioMed Innovations Inc., where cutting-edge medical research transforms patient care. We seek a Senior Medical Research Scientist to lead groundbreaking studies in therapeutic development. Enjoy state-of-the-art facilities, collaborative interdisciplinary teams, and the opportunity to publish in leading journals. Our Boston campus offers unparalleled access to Harvard Medical School and MIT research networks. What You'll Achieve: Design and execute clinical trials, publish high-impact studies, mentor junior researchers, and contribute to FDA-approved therapies. Why Us: We offer competitive benefits, flexible work arrangements, and a commitment to work-life balance. Help shape the future of medicine while advancing your career in one of the world's most innovative healthcare ecosystems.
Responsibilities
- Lead design, execution, and analysis of Phase I-III clinical trials in oncology and immunology
- Develop novel research methodologies and statistical models for therapeutic efficacy studies
- Collaborate with regulatory affairs team to ensure FDA/EMA compliance in trial protocols
- Present findings at international conferences and publish in peer-reviewed journals (NEJM, Lancet)
- Mentor 3-5 junior researchers and coordinate cross-functional project teams
- Secure $2M+ in annual NIH/NSF grant funding through compelling proposals
- Oversee lab operations including budget management, equipment procurement, and vendor relations
Qualifications
- PhD in Life Sciences, Pharmacology, or related field with 8+ years industry experience
- Proven track record of 5+ FDA-approved therapeutic developments or IND submissions
- Expertise in oncology/immunology with 15+ peer-reviewed publications (h-index >20)
- Certification in Good Clinical Practice (GCP) and ICH-GCP guidelines
- Advanced proficiency in statistical software (R, SAS, Prism) and clinical trial databases (Medidata Rave)
- Experience managing $1M+ research budgets and cross-functional teams of 10+
- Strong industry connections with CROs, academic institutions, and biotech partners
- Eligible for US security clearance (if applicable to government-funded projects)